Silence Therapeutics's total assets for Q2 2025 were £165.23M, a decrease of -10.83% from the previous quarter. SLN total liabilities were £71.08M for the fiscal quarter, a -2.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.